Repeatability is the hard part of portfolio AI: a bespoke win in one company rarely transfers to the next, so firms end up with thirty experiments instead of one program. AI revenue recovery scales because it works on something every company already has — a history of referral and partner relationships — and scores each against its own baseline, which is sector-agnostic. The same diagnostic runs identically on a healthcare operator, a services business, or a distributor, on existing data without a long custom build, so it can be deployed company by company with comparable, benchmarkable results.
- Bespoke pilots don't transfer — different stacks and sectors mean re-engineering each time.
- Recovery's core is sector-agnostic — scoring relationships against their own baseline works anywhere.
- It runs on existing data — no long custom build per company.
- Identical method = comparable results — one benchmarkable view across the portfolio.
Why pilots don't become programs
The single most common failure in portfolio AI is not a failed pilot — it's a successful one that goes nowhere. A firm gets a real result in one portfolio company, tries to repeat it in the next, and discovers the win was bespoke: built around that company's particular stack, data model, and sector. Re-creating it elsewhere costs nearly as much as the original, so the firm quietly accumulates a drawer of one-off experiments instead of a program. With 8 or 15 or 30 companies at different stages, the question that actually matters is not "can AI work here?" but "can the same thing work everywhere?" — and most AI initiatives have no good answer.
The sector-agnostic core
Revenue recovery answers it because its core operation is the same regardless of what a company does. Every business that grows through referral or partner relationships has a history of those relationships, and the diagnostic does one sector-agnostic thing: it scores each relationship against its own baseline cadence to find the ones that have gone quiet. A discharge planner who stopped referring and a distributor who stopped ordering are the same pattern to the method, even though the businesses are nothing alike. That universality is what makes the playbook portable — you are not rebuilding a model per company, you are running the same logic on each company's own data.
Estimate the recoverable revenue in a single portfolio company.
The free Revenue Recovery tool gives a benchmark-calibrated range in 90 seconds — then run it across the book. No email required.
Open the free tool →Deploying in waves
Because the method is identical company to company, deployment becomes an operations problem rather than a research problem — and operations problems scale. The practical pattern is to prioritise companies by recoverable-revenue potential, run the diagnostic in waves rather than all at once, and standardise the reactivation playbook and reporting so each engagement looks like the last. A company at the start of a hold and one approaching exit run the same diagnostic; what differs is how the result is used, not how it is produced. That predictability lets an operating partner plan recovery across the portfolio on a cadence, the way they would any repeatable value-creation initiative.
The benchmark advantage
There is a compounding benefit to running one method everywhere: the results are comparable. When every company is measured the same way, an operating partner can benchmark them against each other — which companies carry the most dormancy, which have the most concentration risk, where the recoverable revenue is largest. That cross-portfolio view is impossible when each company ran a different bespoke pilot, and it is genuinely valuable: it tells the firm where to direct attention and capital next. A repeatable method doesn't just scale a tactic; it turns the whole portfolio into a single, legible dataset. On qualifying $30M+ engagements the recovery work carries our 3× fee recovery guarantee: we recover at least three times our fee, or we keep working at no additional fee until we do.
FAQ.
Why is repeatability the hard part of portfolio AI?
Because a one-off win in a single company rarely transfers. Each has a different stack, sector, and data model, so a bespoke project built for one doesn't run on the next, and the firm ends up with thirty experiments instead of one program. Repeatability — a method that produces results the same way everywhere — is what turns scattered pilots into a value-creation lever.
What makes AI revenue recovery repeatable across portfolio companies?
It works on something every company already has: a history of referral and partner relationships. Scoring each against its own baseline is sector-agnostic — the same logic applies to a healthcare operator, a services business, or a distributor — and it runs on existing data without a long custom build, so it deploys company by company on a predictable cadence.
How do you deploy revenue recovery across a whole portfolio?
Run the same diagnostic on each company in waves, prioritised by recoverable-revenue potential, and standardise the reactivation playbook and reporting so results are comparable. Because the method is identical, the operating partner gets a consistent, benchmarkable view rather than a patchwork of incomparable pilots.
How to start.
Here is the fastest path to a real answer. No leap. A stair.
Run the free tool
Five inputs. Sixty seconds. A recoverable-revenue range for one company — then scale it. No email required.
The PE AI value gap
Why revenue is the lever that hits the P&L — and scales.
Book a 30-min qualification call
Julia or Tyler personally. We scope a portfolio-wide rollout. No pitch.